Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: Boplicity who wrote (7382)	4/30/2002 10:16:02 AM
From: D.B. Cooper	Read Replies (1) \| Respond to of 13815

Bop Do you still have this one? Press Release SOURCE: Bradley Pharmaceuticals, Inc. Bradley Pharmaceuticals Announces Record-Breaking First Quarter 2002 Driven by Sales of New Products and Strong Base Sales, 1st Quarter Revenue Up 76%, Profit Up 466% FAIRFIELD, N.J., April 30 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc., (Nasdaq: BPRX - news) today announced that Net Sales for the First Quarter, ended March 31, 2002, totaled $9.3 million, an increase of $4.0 million, or 76% compared to Net Sales reported for the First Quarter 2001. Net Income for the First Quarter reached $1.7 million, up $1.4 million, or 466% compared to a similar period in 2001 with Earnings Per Share of $0.15 (diluted), an increase of $0.11, or 275% over year ago First Quarter. President and CEO, Daniel Glassman, stated, "We are proud to announce that Bradley has delivered another record-breaking quarter. The continued success Bradley achieved in First Quarter 2002 is a result of a carefully planned strategy to bring shareholders the highest return on investment. The core of that strategy is to address the needs of the physician. This drives Bradley product development, promotional planning and sales tactics. All at Bradley are keenly aware that nothing happens until the doctor writes a prescription. As a result, more physicians are writing more prescriptions for more Bradley brands more often for more conditions." New prescription data, generally accepted by the industry as the predictor of future sales, continues to reach new highs. During the First Quarter 2002, the latest time period for which data are available, Bradley achieved 157,000 new prescriptions, written for its key promoted products. This is a 51% increase over the level achieved in the same time period of 2001. I am starting to smell some hair burning. I hope it is not some of the short people.